Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

OSCR vs UNH

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
OSCR
Oscar Health, Inc.

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$5.14B
5Y Perf.-26.2%
UNH
UnitedHealth Group Incorporated

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$333.37B
5Y Perf.-1.3%

OSCR vs UNH — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
OSCR logoOSCR
UNH logoUNH
IndustryMedical - Healthcare PlansMedical - Healthcare Plans
Market Cap$5.14B$333.37B
Revenue (TTM)$13.30B$449.71B
Net Income (TTM)$-39M$12.04B
Gross Margin6.7%18.8%
Operating Margin0.1%4.2%
Forward P/E32.9x20.1x
Total Debt$430M$78.39B
Cash & Equiv.$2.77B$24.36B

OSCR vs UNHLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

OSCR
UNH
StockMar 21May 26Return
Oscar Health, Inc. (OSCR)10073.8-26.2%
UnitedHealth Group … (UNH)10098.7-1.3%

Price return only. Dividends and distributions are not included.

Quick Verdict: OSCR vs UNH

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: UNH leads in 5 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Oscar Health, Inc. is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
OSCR
Oscar Health, Inc.
The Insurance Pick

OSCR is the clearest fit if your priority is growth exposure and sleep-well-at-night.

  • Rev growth 27.5%, EPS growth -18.7%, 3Y rev CAGR 41.6%
  • Lower volatility, beta 1.84, Low D/E 43.9%, current ratio 0.95x
  • 27.5% revenue growth vs UNH's 11.8%
Best for: growth exposure and sleep-well-at-night
UNH
UnitedHealth Group Incorporated
The Insurance Pick

UNH carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 25 yrs, beta 0.59, yield 2.4%
  • 220.3% 10Y total return vs OSCR's -43.0%
  • Beta 0.59, yield 2.4%, current ratio 0.79x
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthOSCR logoOSCR27.5% revenue growth vs UNH's 11.8%
ValueUNH logoUNHLower P/E (20.1x vs 32.9x)
Quality / MarginsUNH logoUNHCombined ratio 1.0 vs OSCR's 1.0 (lower = better underwriting)
Stability / SafetyUNH logoUNHBeta 0.59 vs OSCR's 1.84
DividendsUNH logoUNH2.4% yield; 25-year raise streak; the other pay no meaningful dividend
Momentum (1Y)OSCR logoOSCR+51.8% vs UNH's -4.7%
Efficiency (ROA)UNH logoUNH3.9% ROA vs OSCR's -0.6%

OSCR vs UNH — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

OSCROscar Health, Inc.

Segment breakdown not available.

UNHUnitedHealth Group Incorporated
FY 2025
Unitedhealthcare
94.4%$332.4B
Optumhealth
5.6%$19.8B

OSCR vs UNH — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLOSCRLAGGINGUNH

Income & Cash Flow (Last 12 Months)

Evenly matched — OSCR and UNH each lead in 3 of 6 comparable metrics.

UNH is the larger business by revenue, generating $449.7B annually — 33.8x OSCR's $13.3B. Profitability is closely matched — net margins range from 2.7% (UNH) to -0.3% (OSCR). On growth, OSCR holds the edge at +52.6% YoY revenue growth, suggesting stronger near-term business momentum.

MetricOSCR logoOSCROscar Health, Inc.UNH logoUNHUnitedHealth Grou…
RevenueTrailing 12 months$13.3B$449.7B
EBITDAEarnings before interest/tax$40M$23.2B
Net IncomeAfter-tax profit-$39M$12.0B
Free Cash FlowCash after capex$2.8B$19.7B
Gross MarginGross profit ÷ Revenue+6.7%+18.8%
Operating MarginEBIT ÷ Revenue+0.1%+4.2%
Net MarginNet income ÷ Revenue-0.3%+2.7%
FCF MarginFCF ÷ Revenue+21.0%+4.4%
Rev. Growth (YoY)Latest quarter vs prior year+52.6%+2.0%
EPS Growth (YoY)Latest quarter vs prior year+125.0%+0.7%
Evenly matched — OSCR and UNH each lead in 3 of 6 comparable metrics.

Valuation Metrics

OSCR leads this category, winning 3 of 5 comparable metrics.
MetricOSCR logoOSCROscar Health, Inc.UNH logoUNHUnitedHealth Grou…
Market CapShares × price$5.1B$333.4B
Enterprise ValueMkt cap + debt − cash$2.8B$387.4B
Trailing P/EPrice ÷ TTM EPS-11.74x27.76x
Forward P/EPrice ÷ next-FY EPS est.32.94x20.06x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple16.61x
Price / SalesMarket cap ÷ Revenue0.44x0.74x
Price / BookPrice ÷ Book value/share5.31x3.29x
Price / FCFMarket cap ÷ FCF4.86x20.74x
OSCR leads this category, winning 3 of 5 comparable metrics.

Profitability & Efficiency

UNH leads this category, winning 5 of 8 comparable metrics.

UNH delivers a 11.5% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-3 for OSCR. OSCR carries lower financial leverage with a 0.44x debt-to-equity ratio, signaling a more conservative balance sheet compared to UNH's 0.77x. On the Piotroski fundamental quality scale (0–9), UNH scores 6/9 vs OSCR's 4/9, reflecting solid financial health.

MetricOSCR logoOSCROscar Health, Inc.UNH logoUNHUnitedHealth Grou…
ROE (TTM)Return on equity-3.3%+11.5%
ROA (TTM)Return on assets-0.6%+3.9%
ROICReturn on invested capital+9.2%
ROCEReturn on capital employed-25.3%+9.7%
Piotroski ScoreFundamental quality 0–946
Debt / EquityFinancial leverage0.44x0.77x
Net DebtTotal debt minus cash-$2.3B$54.0B
Cash & Equiv.Liquid assets$2.8B$24.4B
Total DebtShort + long-term debt$430M$78.4B
Interest CoverageEBIT ÷ Interest expense-42.02x4.71x
UNH leads this category, winning 5 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

OSCR leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in UNH five years ago would be worth $9,746 today (with dividends reinvested), compared to $9,072 for OSCR. Over the past 12 months, OSCR leads with a +51.8% total return vs UNH's -4.7%. The 3-year compound annual growth rate (CAGR) favors OSCR at 38.2% vs UNH's -7.3% — a key indicator of consistent wealth creation.

MetricOSCR logoOSCROscar Health, Inc.UNH logoUNHUnitedHealth Grou…
YTD ReturnYear-to-date+32.5%+9.8%
1-Year ReturnPast 12 months+51.8%-4.7%
3-Year ReturnCumulative with dividends+163.8%-20.4%
5-Year ReturnCumulative with dividends-9.3%-2.5%
10-Year ReturnCumulative with dividends-43.0%+220.3%
CAGR (3Y)Annualised 3-year return+38.2%-7.3%
OSCR leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

UNH leads this category, winning 2 of 2 comparable metrics.

UNH is the less volatile stock with a 0.59 beta — it tends to amplify market swings less than OSCR's 1.84 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. UNH currently trades 90.7% from its 52-week high vs OSCR's 83.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricOSCR logoOSCROscar Health, Inc.UNH logoUNHUnitedHealth Grou…
Beta (5Y)Sensitivity to S&P 5001.84x0.59x
52-Week HighHighest price in past year$23.80$404.72
52-Week LowLowest price in past year$10.69$234.60
% of 52W HighCurrent price vs 52-week peak+83.4%+90.7%
RSI (14)Momentum oscillator 0–10069.974.5
Avg Volume (50D)Average daily shares traded6.4M8.1M
UNH leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates OSCR as "Hold" and UNH as "Buy". Consensus price targets imply 4.9% upside for UNH (target: $385) vs -15.6% for OSCR (target: $17). UNH is the only dividend payer here at 2.37% yield — a key consideration for income-focused portfolios.

MetricOSCR logoOSCROscar Health, Inc.UNH logoUNHUnitedHealth Grou…
Analyst RatingConsensus buy/hold/sellHoldBuy
Price TargetConsensus 12-month target$16.75$385.43
# AnalystsCovering analysts1152
Dividend YieldAnnual dividend ÷ price+2.4%
Dividend StreakConsecutive years of raises25
Dividend / ShareAnnual DPS$8.70
Buyback YieldShare repurchases ÷ mkt cap0.0%+1.7%
Insufficient data to determine a leader in this category.
Key Takeaway

OSCR leads in 2 of 6 categories (Valuation Metrics, Total Returns). UNH leads in 2 (Profitability & Efficiency, Risk & Volatility). 1 tied.

Best OverallOscar Health, Inc. (OSCR)Leads 2 of 6 categories
Loading custom metrics...

OSCR vs UNH: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is OSCR or UNH a better buy right now?

For growth investors, Oscar Health, Inc.

(OSCR) is the stronger pick with 27. 5% revenue growth year-over-year, versus 11. 8% for UnitedHealth Group Incorporated (UNH). UnitedHealth Group Incorporated (UNH) offers the better valuation at 27. 8x trailing P/E (20. 1x forward), making it the more compelling value choice. Analysts rate UnitedHealth Group Incorporated (UNH) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — OSCR or UNH?

On forward P/E, UnitedHealth Group Incorporated is actually cheaper at 20.

1x.

03

Which is the better long-term investment — OSCR or UNH?

Over the past 5 years, UnitedHealth Group Incorporated (UNH) delivered a total return of -2.

5%, compared to -9. 3% for Oscar Health, Inc. (OSCR). Over 10 years, the gap is even starker: UNH returned +220. 3% versus OSCR's -43. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — OSCR or UNH?

By beta (market sensitivity over 5 years), UnitedHealth Group Incorporated (UNH) is the lower-risk stock at 0.

59β versus Oscar Health, Inc. 's 1. 84β — meaning OSCR is approximately 213% more volatile than UNH relative to the S&P 500. On balance sheet safety, Oscar Health, Inc. (OSCR) carries a lower debt/equity ratio of 44% versus 77% for UnitedHealth Group Incorporated — giving it more financial flexibility in a downturn.

05

Which is growing faster — OSCR or UNH?

By revenue growth (latest reported year), Oscar Health, Inc.

(OSCR) is pulling ahead at 27. 5% versus 11. 8% for UnitedHealth Group Incorporated (UNH). On earnings-per-share growth, the picture is similar: UnitedHealth Group Incorporated grew EPS -14. 7% year-over-year, compared to -1865. 9% for Oscar Health, Inc.. Over a 3-year CAGR, OSCR leads at 41. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — OSCR or UNH?

UnitedHealth Group Incorporated (UNH) is the more profitable company, earning 2.

7% net margin versus -3. 8% for Oscar Health, Inc. — meaning it keeps 2. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UNH leads at 4. 2% versus -3. 4% for OSCR. At the gross margin level — before operating expenses — UNH leads at 18. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is OSCR or UNH more undervalued right now?

On forward earnings alone, UnitedHealth Group Incorporated (UNH) trades at 20.

1x forward P/E versus 32. 9x for Oscar Health, Inc. — 12. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for UNH: 4. 9% to $385. 43.

08

Which pays a better dividend — OSCR or UNH?

In this comparison, UNH (2.

4% yield) pays a dividend. OSCR does not pay a meaningful dividend and should not be held primarily for income.

09

Is OSCR or UNH better for a retirement portfolio?

For long-horizon retirement investors, UnitedHealth Group Incorporated (UNH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

59), 2. 4% yield, +220. 3% 10Y return). Oscar Health, Inc. (OSCR) carries a higher beta of 1. 84 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (UNH: +220. 3%, OSCR: -43. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between OSCR and UNH?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: OSCR is a small-cap high-growth stock; UNH is a large-cap quality compounder stock. UNH pays a dividend while OSCR does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

OSCR

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 26%
Run This Screen
Stocks Like

UNH

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Dividend Yield > 0.9%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform OSCR and UNH on the metrics below

Revenue Growth>
%
(OSCR: 52.6% · UNH: 2.0%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.